which glp 1 has less side effects GLP-1 medication for diabetes and weight loss Updated Ranking and Side Effects
Description
Pfizer halted development of its oral GLP-1 danuglipron in 2025 after a trial participant developed liver injury, reflecting safety concerns that require ongoing monitoring with real-world data
[DOI] [PubMed] [Google Scholar] 8.Tan Z., Chin A., Welman C.J., Thin L
Send your prescription to Strive Pharmacy for compounding
doi: 10.2337/diab.4.5.367
Our licensed compounding pharmacists serve as a clinical resource for providers, offering guidance on available dosage forms, formulation considerations, and preparation options when standard medications are not suitable
